Source:http://linkedlifedata.com/resource/pubmed/id/19935144
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2009-11-25
|
| pubmed:grant | |
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1546-4156
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
23
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
303-5
|
| pubmed:dateRevised |
2011-2-14
|
| pubmed:meshHeading |
pubmed-meshheading:19935144-Alzheimer Disease,
pubmed-meshheading:19935144-Arizona,
pubmed-meshheading:19935144-Cholesterol,
pubmed-meshheading:19935144-Cognition Disorders,
pubmed-meshheading:19935144-Humans,
pubmed-meshheading:19935144-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19935144-Risk Factors
|
| pubmed:articleTitle |
On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.
|
| pubmed:publicationType |
Editorial,
Comment
|